Literature DB >> 4715144

The clinical features of haemoglobin SC disease in Jamaica.

G R Serjeant, M T Ashcroft, B E Serjeant.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4715144     DOI: 10.1111/j.1365-2141.1973.tb01675.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

1.  Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.

Authors:  H R Gralnick; B S Coller; Y Sultan
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

2.  Sickle cell haemoglobinopathies in England.

Authors:  J R Mann
Journal:  Arch Dis Child       Date:  1981-09       Impact factor: 3.791

3.  Sickle cell disease in Britain.

Authors:  M Brozović; E Anionwu
Journal:  J Clin Pathol       Date:  1984-12       Impact factor: 3.411

4.  Sickle-cell disease in a British urban community.

Authors:  E Anionwu; D Walford; M Brozović; B Kirkwood
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-24

5.  Exchange transfusion in life-threatening sickling crises.

Authors:  J E Van de Pette; T C Pearson; N G Slater
Journal:  J R Soc Med       Date:  1982-10       Impact factor: 18.000

6.  Hydroxyurea decreases hospitalizations in pediatric patients with Hb SC and Hb SB+ thalassemia.

Authors:  Jeffrey D Lebensburger; Rakeshkumar J Patel; Prasannalaxmi Palabindela; Christina J Bemrich-Stolz; Thomas H Howard; Lee M Hilliard
Journal:  J Blood Med       Date:  2015-12-15

7.  [>Femoral bone infarction revealing compound heterozygous SC sickle cell disease in a Moroccan patient].

Authors:  Fatima-Zahrae Bennis; Asmae Biaz; Aida Zkik; Achraf Rachid; Sanae Bouhsain; Abdellah Dami; Elmachtani Idrissi Samira
Journal:  Pan Afr Med J       Date:  2020-08-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.